Free Trial

Smith & Nephew (LON:SN) Share Price Passes Above 200 Day Moving Average - Time to Sell?

Smith & Nephew logo with Medical background

Smith & Nephew plc (LON:SN - Get Free Report)'s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,147.68 ($15.56) and traded as high as GBX 1,379.50 ($18.70). Smith & Nephew shares last traded at GBX 1,371 ($18.58), with a volume of 2,589,963 shares trading hands.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Berenberg Bank upped their price objective on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the company a "hold" rating in a research note on Thursday, August 7th. JPMorgan Chase & Co. upped their price objective on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the company an "overweight" rating in a research note on Wednesday, August 6th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a "hold" rating in a research report on Wednesday, August 6th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of GBX 1,379.33.

Get Our Latest Stock Report on SN

Smith & Nephew Price Performance

The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The business has a 50-day moving average price of GBX 1,293.27 and a 200 day moving average price of GBX 1,147.68. The stock has a market cap of £15.03 billion, a PE ratio of 49.36, a PEG ratio of 0.46 and a beta of 0.62.

Insider Buying and Selling at Smith & Nephew

In related news, insider Katarzyna Mazur Hofsaess acquired 541 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The shares were acquired at an average price of GBX 1,385 per share, with a total value of £7,492.85. Also, insider Jeremy (Jez) Maiden acquired 353 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The shares were bought at an average cost of GBX 1,378 per share, for a total transaction of £4,864.34. Insiders have bought a total of 4,811 shares of company stock worth $12,947,701 in the last three months. 0.19% of the stock is currently owned by corporate insiders.

Smith & Nephew Company Profile

(Get Free Report)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Smith & Nephew Right Now?

Before you consider Smith & Nephew, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.

While Smith & Nephew currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.